Giuliani, Daniela

Efferent Vagal Fibre Stimulation Blunts Nuclear Factor-κB Activation and Protects Against Hypovolemic Hemorrhagic Shock

Guarini, S., Altavilla, D., Cainazzo, M.-M., Giuliani, D., Bigiani, A., Marini, H., Squadrito, G., Minutoli, L., Bertolini, A., Marini, R., et al. (2003) · Circulation

Vagus Nerve Stimulation ResearchHeart Rate Variability and Autonomic Control

Cited by 315

Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats*

Mioni, C., Bazzani, C., Giuliani, D., Altavilla, D., Leone, S., Ferrari, A., Minutoli, L., Bitto, A., Marini, H., Zaffe, D., et al. (2005) · Critical Care Medicine

Cardiac Ischemia and ReperfusionVagus Nerve Stimulation Research

Cited by 148

ACTIVATION OF THE CHOLINERGIC ANTI-INFLAMMATORY PATHWAY REDUCES NF-κB ACTIVATION, BLUNTS TNF-α PRODUCTION, AND PROTECTS AGAINTS SPLANCHIC ARTERY OCCLUSION SHOCK

Altavilla, D., Guarini, S., Bitto, A., Mioni, C., Giuliani, D., Bigiani, A., Squadrito, G., Minutoli, L., Venuti, F. S., Messineo, F., et al. (2006) · Shock

Vagus Nerve Stimulation ResearchHeart Rate Variability and Autonomic Control

Cited by 98

Neuroprotection in focal cerebral ischemia owing to delayed treatment with melanocortins

Giuliani, D., Ottani, A., Mioni, C., Bazzani, C., Galantucci, M., Minutoli, L., Bitto, A., Zaffe, D., Botticelli, A. R., Squadrito, F., et al. (2007) · European Journal of Pharmacology

Neuropeptides and Animal PhysiologyNeuroprotection in Cerebral Ischemia

Cited by 44

PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice

Vilella, A., Bodria, M., Papotti, B., Zanotti, I., Zimetti, F., Remaggi, G., Elviri, L., Potì, F., Ferri, N., Lupo, M. G., et al. (2024) · Brain, Behavior, and Immunity

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 43

PCSK9 affects astrocyte cholesterol metabolism and reduces neuron cholesterol supplying in vitro: potential implications in Alzheimer’s disease

Papotti, B., Adorni, M. P., Marchi, C., Zimetti, F., Ronda, N., Panighel, G., Lupo, M. G., Vilella, A., Giuliani, D., Ferri, N., et al. (2022) · International Journal of Molecular Sciences

Alzheimer's disease research and treatmentsCholesterol and Lipid Metabolism

Cited by 41

Multiple beneficial effects of melanocortin MC4 receptor agonists in experimental neurodegenerative disorders: Therapeutic perspectives

Giuliani, D., Ottani, A., Neri, L., Zaffe, D., Grieco, P., Jochem, J., Cavallini, G. M., Catania, A., & Guarini, S. (2017) · Progress in Neurobiology

Neuropeptides and Animal PhysiologyNeuroinflammation and Neurodegeneration Mechanisms

Cited by 38

Protective effects of the melanocortin analog NDP-α-MSH in rats undergoing cardiac arrest

Ottani, A., Neri, L., Canalini, F., Calevro, A., Rossi, R., Cappelli, G., Ballestri, M., Giuliani, D., & Guarini, S. (2014) · European Journal of Pharmacology

Cardiac Arrest and ResuscitationCardiac Ischemia and Reperfusion

Cited by 19